ADVERSE EVENTS ASSOCIATED WITH COLCHICINE DRUG INTERACTIONS: ANALYSIS OF THE PUBLIC VERSION OF THE FDA ADVERSE EVENT REPORTING SYSTEM

被引：0
|
作者：
Almalki, Z. [1 ]
Guo, J. J. [1 ]
Kelton, C. M. [2 ]
Wigle, P. R. [1 ]
机构：
[1] Univ Cincinnati, Coll Pharm, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Coll Business, Cincinnati, OH USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1105
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A218 / A218
页数：1
相关论文
共 50 条
  • [1] Adverse Events Associated with Colchicine Drug Interactions: Analysis of the Public Version of the FDA Adverse Event Reporting System
    Almalki, Ziyad S.
    Guo, Jeff J.
    Kelton, Christina M. L.
    Wigle, Patricia R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 83 - 84
  • [2] Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System
    Sakaeda, Toshiyuki
    Kadoyama, Kaori
    Okuno, Yasushi
    PLOS ONE, 2011, 6 (12):
  • [3] Vedolizumab Adverse Events: Analysis of the FDA Adverse Event Reporting System
    Jow, Steven
    Hutfless, Susan
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S35 - S36
  • [4] Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)
    Xiong, Xiaomei
    Zhang, Xiuwen
    Li, Xiaoxia
    Huang, Taomin
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (11) : 1447 - 1452
  • [5] Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
    Shu, Yamin
    Ding, Yiling
    Liu, Lulu
    Zhang, Qilin
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (09) : 2705 - 2716
  • [6] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Shu-peng Zou
    Hai-yun Yang
    Meng-ling Ouyang
    Qian Cheng
    Xuan Shi
    Ming-hui Sun
    BMC Pharmacology and Toxicology, 24
  • [7] Fosfomycin-associated adverse events: A disproportionality analysis of the FDA Adverse Event Reporting System
    Yang, Luxuan
    Zhang, Wenyong
    Shen, Xiujuan
    Liu, Meiqin
    Wu, Meiying
    Xiao, Dan
    DRUG DISCOVERIES AND THERAPEUTICS, 2025,
  • [8] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Zou, Shu-peng
    Yang, Hai-yun
    Ouyang, Meng-ling
    Cheng, Qian
    Shi, Xuan
    Sun, Ming-hui
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [9] Data Mining of the Public Version of the FDA Adverse Event Reporting System
    Sakaeda, Toshiyuki
    Tamon, Akiko
    Kadoyama, Kaori
    Okuno, Yasushi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (07): : 796 - 803
  • [10] DRUGS ASSOCIATED WITH ADVERSE DRUG EVENTS IN CHILDREN: ANALYSIS OF THE UNITED STATES FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Lee, W. J.
    Schumock, G. T.
    Lee, T. A.
    VALUE IN HEALTH, 2013, 16 (03) : A70 - A70
12345